FASLG and Alzheimer disease: In particular, serum levels of IL-6, sFasL and the soluble cytokeratin CK18-M65 and its caspase‐cleaved fragment CK18-M30 were significantly elevated in AD (P<0.01) (Fig 1, Table 3).